Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
7
×
clinical trials
life sciences
national blog main
fda
national top stories
new york top stories
san francisco top stories
boston blog main
boston top stories
europe top stories
indiana blog main
indiana top stories
medical devices
national
new york blog main
novartis
roche
san diego blog main
san diego top stories
san francisco blog main
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
europe blog main
investing
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
type 1 diabetes
venture capital
wisconsin blog main
wisconsin top stories
abeona therapeutics
accent therapeutics
What
patients
7
×
fda
drug
new
biofourmis
daily
digital
gets
home
market
medicine
therapy
type
wearable
add
advantages
analytics
app
approval
approved
atrophy
bar
based
bid
bio
boehringer
boston
breakthrough
brings
called
cancer
carbidopa
closer
combination
company
control
data
designation
device
devices
Language
unset
7
×
Current search:
patients
×
biotech
×
unset
×
@techcrunch.com
2 years ago
Biofourmis receives FDA breakthrough device designation for heart failure “digital therapy”
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone